Sclerostin quo vadis? - Is this a useful long-term mortality parameter in prevalent hemodialysis patients?

Nowak, Albina; Artunc, Ferruh; Serra, Andreas L.; Pollock, Emily; Krayenbuehl, Pierre-Alexandre; Mueller, Christian; Friedrich, Bjoern

dc.contributor.author	Artunç, Ferruh Hâdi
dc.date.accessioned	2015-10-14T13:20:25Z
dc.date.available	2015-10-14T13:20:25Z
dc.date.issued	2015
dc.identifier.issn	1420-4096
dc.identifier.uri	http://hdl.handle.net/10900/65553
dc.language.iso	en	de_DE
dc.publisher	Karger	de_DE
dc.relation.uri	http://dx.doi.org/10.1159/000368502	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Sclerostin quo vadis? - Is this a useful long-term mortality parameter in prevalent hemodialysis patients?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_02014
utue.publikation.seiten	266-276	de_DE
utue.personen.roh	Nowak, Albina
utue.personen.roh	Artunc, Ferruh
utue.personen.roh	Serra, Andreas L.
utue.personen.roh	Pollock, Emily
utue.personen.roh	Krayenbuehl, Pierre-Alexandre
utue.personen.roh	Mueller, Christian
utue.personen.roh	Friedrich, Bjoern
dcterms.isPartOf.ZSTitelID	Kidney & Blood Pressure Research	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	40	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE